Carregant...
PELP-1 regulates adverse responses to endocrine therapy in Estrogen Receptor (ER) positive breast cancer
Introduction: Endocrine therapy has played an important role in the management of ER positive breast cancer over recent decades. Despite this, not all patients respond equally to endocrine intervention, which can lead to resistance, associated disease relapse and progression. Previous reports sugges...
Guardat en:
| Publicat a: | Oncotarget |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Impact Journals LLC
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7771710/ https://ncbi.nlm.nih.gov/pubmed/33473257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27846 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|